Finerenone continues to impress in diabetic kidney disease space: GlobalData
New data confirms Kerendia’s kidney and heart benefits hold strong in diabetic CKD patients, regardless of early eGFR dips, easing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
finerenone
FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death
The study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for HF patients, which…
Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa
Bayer submits application in EU for extension of finerenone to include early stages of CKD…
Regulatory submission is based on positive data from the pivotal phase-III FIGARO-DKD study, published in the 'New England Journal…
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes
It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…